Show simple item record

dc.contributor.authorGopalsamuthiram, Vijayagopal
dc.contributor.authorKadam, Appasaheb L
dc.contributor.authorNoble, Jeffrey K
dc.contributor.authorSnead, David R
dc.contributor.authorWilliams, Corshai
dc.contributor.authorJamison, Timothy F
dc.contributor.authorSenanayake, Chris
dc.contributor.authorYadaw, Ajay K
dc.contributor.authorRoy, Sarabindu
dc.contributor.authorSirasani, Gopal
dc.contributor.authorGupton, B Frank
dc.contributor.authorBurns, Justina
dc.contributor.authorCook, Daniel W
dc.contributor.authorStringham, Rodger W
dc.contributor.authorAhmad, Saeed
dc.contributor.authorKrack, Rudy
dc.date.accessioned2022-03-09T15:41:12Z
dc.date.available2022-03-09T15:41:12Z
dc.date.issued2021-12-17
dc.identifier.urihttps://hdl.handle.net/1721.1/141084
dc.description.abstractA scalable four-step synthesis of molnupiravir from cytidine is described herein. The attractiveness of this approach is its fully chemical nature involving inexpensive reagents and more environmentally friendly solvents such as water, isopropanol, acetonitrile, and acetone. Isolation and purification procedures are improved in comparison to our earlier study as all intermediates can be isolated via recrystallization. The key steps in the synthesis, namely, ester formation, hydroxyamination, and deprotection were carried out on a multigram scale to afford molnupiravir in 36-41% yield with an average purity of 98 wt % by qNMR and 99 area% by HPLC.en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionof10.1021/acs.oprd.1c00219en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourceACSen_US
dc.titleToward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesisen_US
dc.typeArticleen_US
dc.identifier.citationGopalsamuthiram, Vijayagopal, Kadam, Appasaheb L, Noble, Jeffrey K, Snead, David R, Williams, Corshai et al. 2021. "Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis." Organic Process Research & Development, 25 (12).
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistry
dc.relation.journalOrganic Process Research & Developmenten_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2022-03-09T15:35:58Z
dspace.orderedauthorsGopalsamuthiram, V; Kadam, AL; Noble, JK; Snead, DR; Williams, C; Jamison, TF; Senanayake, C; Yadaw, AK; Roy, S; Sirasani, G; Gupton, BF; Burns, J; Cook, DW; Stringham, RW; Ahmad, S; Krack, Ren_US
dspace.date.submission2022-03-09T15:36:00Z
mit.journal.volume25en_US
mit.journal.issue12en_US
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work and Publication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record